At least three promising antivirals for COVID are being tested in clinical trials, with results expected as soon as late fall or winter, said Carl Dieffenbach, director of the Division of AIDS at the National Institute of Allergy and Infectious Diseases, who is overseeing antiviral development.
from Section Page News - Modern Healthcare https://ift.tt/3o3l5w8
